In a story about limited access to weight-loss prescription medications, Jonathan Purnell, M.D., advises against obtaining medications formulated at compounding pharmacies and notes that anti-fat bias can make some health providers reluctant to prescribe these medications.

In a BusinessWire press release from Scale Biosciences on the expansion of their product portfolio to enable a broader range of single cell omics experiments, Andrew Adey, Ph.D., says "The research community needs a robust solution to scale single cell methylation analysis and help unlock new understandings of the relationship between genomics, epigenetics and human health.”

Researchers at Oregon State University and OHSU are testing a way to deliver treatment for ectopic pregnancies in a far more targeted way.

Continued coverage on a first-known study led by Bethany Samuelson Bannow, M.D., finds many menstrual products had a much lower or higher liquid capacity than advertised when real blood was used instead of a saline solution more commonly employed in the product development process.

In an Atsena Therapeutics press release announcing the first dose being given for a clinical trial evaluating an experimental gene therapy for the vision-threatening condition retinitis pigmentosa, Mark Pennesi, M.D., Ph.D., says: "Considering the lack of available therapies for X-linked retinoschisis, this is very exciting news for the inherited retinal disease community.”

An OPB News story profiles Doernbecher Children's Hospital's Therapeutic Gaming Program, designed to help children cope with stressful places like hospitals. The program is led by Sam Giles LeBlanc who says: “If you’re stuck in a hospital bed all day every day, then to have this feeling of a whole world that you can explore, you know, it’s like books, but on a different level because you’re personally exploring that world.”

Continued coverage on a first-known study led by Bethany Samuelson Bannow, M.D., finds many menstrual products had a much lower or higher liquid capacity than advertised when real blood was used instead of a saline solution more commonly employed in the product development process.

An OregonLive Letter from the Editor on unclaimed remains of people in Oregon mentions that OHSU has not accepted indigent remains since 2009.

A Livestrong article on "10 Things Gynecologists Wish You'd Stop Doing at Your Checkups" links to an OHSU Center for Women's Health article noting that painful periods that affect your day-to-day life aren't normal.

Continued coverage on a first-known study led by Bethany Samuelson Bannow, M.D., finds many menstrual products had a much lower or higher liquid capacity than advertised when real blood was used instead of a saline solution more commonly employed in the product development process.